Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06048731 · ClinicalTrials.gov registry record
Enlighten Study: The EV-ICD Post Approval Registry
A clinical trial of Tachycardia and Ventricular Arrhythmia, sponsored by Medtronic.
- Active
- Registry status
- 1,000
- Enrollment target
- 20
- Study locations
NCT06048731: Active study of Tachycardia and Ventricular Arrhythmia, sponsored by Medtronic.
NCT06048731 is a study of Tachycardia and Ventricular Arrhythmia that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 1,000 participants, above the 773-participant average among 8 other Tachycardia trials with a reported enrollment target (29% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06048731, a study of Tachycardia and Ventricular Arrhythmia, is active but no longer recruiting, sponsored by Medtronic.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices.
Primary Outcome
To demonstrate 5-year Aurora EV-ICD major system-related complication-free survival \> 79%
Conditions Studied
Interventions
- DEVICE Defibrillation using EV-ICD
Study Locations (20)
California
- Cardiology Associates Medical Group - Huntington Park
- Sequoia Hospital - Redwood City
- University of California San Diego - San Diego
- Stanford Hospital & Clinics - Stanford
Florida
- Clearwater Cardiovascular Consultants - Clearwater
- Baptist Health - Jacksonville
- Cardiovascular Institute of Northwest Florida - Panama City
- Intercoastal Medical Group - Sarasota
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Woman's Hospital - Boston
Michigan
- Sparrow Clinical Research Institute - Lansing
- Michigan Heart - Ypsilanti
Minnesota
- Metropolitan Cardiology Consultants - Coon Rapids
- Minneapolis Heart Institute Foundation - Minneapolis
Connecticut
- Hartford Hospital - Hartford
Georgia
- Wellstar Research Institute - Marietta
Indiana
- Deaconess Specialty Physicians - Newburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2037-10-31 |
What the registry record for NCT06048731 still lists
NCT06048731 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 773-participant average among 8 other Tachycardia trials with a reported enrollment target (29% higher).
The record links to 2 conditions, with Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Defibrillation using EV-ICD is the first listed.
NCT06048731 names 20 study sites across 11 states, led by California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06048731 about?
NCT06048731 is a clinical study titled "Enlighten Study: The EV-ICD Post Approval Registry". Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices.
What is the current status of trial NCT06048731?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2023-09-01. Estimated completion is 2037-10-31.
What conditions does trial NCT06048731 study?
This clinical trial studies the following conditions: Tachycardia, Ventricular Arrhythmia.
What interventions are being tested in trial NCT06048731?
The interventions under investigation include: Defibrillation using EV-ICD (DEVICE).
Who is sponsoring clinical trial NCT06048731?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06048731 being conducted?
This trial has 20 study locations across California, Connecticut, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06048731's enrollment target sits among peer trials
1,000 3rd of 8 higher than 5 of 8 other Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Treatment of Orthostatic Intolerance
ACTIVE NOT RECRUITING · Phase 1
-
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
ACTIVE NOT RECRUITING
-
Pathophysiology of Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
Cardiac Implantable Electronic Device (CIED) Research Study
ACTIVE NOT RECRUITING
-
RIGHT: Rhythm ID Going Head-to-Head Trial
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI